ArticleEuropean journal of pediatrics2025
Comparison of international league of associations for rheumatology and pediatric rheumatology international trials organization classification criteria for juvenile idiopathic arthritis: insights from an African multicenter cohort.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The International League of Associations for Rheumatology (ILAR) classification criteria for juvenile idiopathic arthritis (JIA) are currently widely used in clinical practice. However, new criteria have recently been proposed by the Pediatric Rheumatology International Trials Organization (PRINTO) and are still under validation. The objective of this study is to compare the ILAR and PRINTO classifications when applied to an African multicenter cohort. We included patients under 18 years of age diagnosed with JIA according to ILAR criteria from the Pediatric African League Against Rheumatism (PAFLAR) registry. Subtypes were reassigned based on PRINTO criteria. Overlaps were assessed using Circos plots and chi-square tests. Overrepresented pairs were defined as those with Z scores ≥ 1.96. Cohen's Kappa was used to assess agreement. A total of 316 patients were included (sex ratio H/F = 0.69; mean age 8.8 ± 4.4 years). ILAR undifferentiated arthritis and PRINTO other JIA accounted for 11.7% and 63% of cases, respectively. Significant overlap was observed between the following ILAR and PRINTO subtypes: rheumatoid factor (RF)-positive polyarthritis/RF-positive JIA (Z = + 14.7), systemic arthritis/systemic JIA (Z = + 13.1), enthesitis-related arthritis (ERA)/enthesitis-spondylitis-related arthritis (Z = + 8.6), oligoarthritis/early-onset antinuclear antibody (ANA)-positive JIA (Z = + 3.7), RF-negative polyarthritis/other JIA (Z = + 2.5), and oligoarthritis/other JIA (Z = + 2.1). The agreement was almost perfect for systemic JIA (κ = 0.864) and RF-positive JIA (κ = 0.885).
conclusionThe PRINTO classification did not reduce the number of unclassifiable cases. Nearly two-thirds of our patients were classified as PRINTO "other JIA". However, it may allow better delineation of homogeneous subgroups, such as early-onset ANA-positive and RF-positive JIA. WHAT IS KNOWN: • The ILAR classification criteria are the most widely used system for categorizing JIA, but it has some limitations, notably the existence of heterogeneous and unclassifiable subgroups. • The PRINTO group proposed new classification criteria to overcome ILAR shortcomings and align pediatric forms of arthritis with adult ones. WHAT IS NEW: • The PRINTO classification did not reduce the number of unclassifiable JIA patients. Two-thirds of the patients remained unclassified using PRINTO criteria. • African JIA patients had a higher frequency of the ERA subtype, common hip involvement, and lower detection of cutaneous rash.
Indexed as
Identifiers
41238778What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.